Link Medicine
	Operator of a privately held biotechnology company advancing novel approaches for the treatment of neurodegenerative diseases. The company is developing treatments for multiple diseases, including Alzheimer’s, Parkinson’s, Huntington’s, and Amyotrophic Lateral Sclerosis (ALS). It targets a common feature of the disorders - the buildup in nerve cells of incorrectly folded, aggregated and ultimately neurotoxic proteins.
	['', 'neurodegenerative disease', ' Alzheimer’s Parkinson’s, Huntington’s ', 'Amyotrophic Lateral Sclerosis', ' ALS']
Corvas
	Manufacturer and developer of therapeutic agents for the prevention and treatment of cardiovascular and inflammatory diseases. The company also undertakes cancer research programs.
	['biotherapeutics ', 'cardiovascular disease', ' ', 'drug candidate', '']
Intracellular Therapies
	Developer of drugs for the treatment of diseases and disorders of the Central Nervous System (CNS). The company develops compounds to treat neuropsychiatric and neurological diseases. It also develops a state of the art technology platform for generating a unique molecular signature for drug compounds.
	['', 'neuropsychiatric disease treatment', ' ', 'neurological disease treatment', ' ', 'drug compound', ' ', 'drug development', '']
StormBio
	Developer of therapy for influenza and other inflammatory diseases. The company is developing a new class of therapeutics designed to target only an over-reaction of the inflammatory process, without shutting down the body\'s immune response.
	['', 'influenza', ' ', 'inflammation treatment', ' ', 'pandemic', ' ', 'biopharm', '']
Centaur Pharmaceuticals
	Developer of novel class of small molecule pharmaceutical compounds for the treatment of neurodegenerative and inflammatory diseases. The company develops such compounds to treat inflammatory diseases such as acute stroke, dementia, rheumatoid arthritis, myocardial ischemia and Parkinson’s disease.
	['', 'molecule pharmaceutical compound', ' ', 'pharmaceutical products', '']
